Myasthenia Gravis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
"Who might be able to join this trial:
- You have been diagnosed with a condition called generalized Myasthenia Gravis (gMG) and are about to start, or have just begun your first cycle of, a treatment called efgartigimod (a commercially available medication).
- Alternatively, you have been diagnosed with generalized Myasthenia Gravis (gMG) but have never received efgartigimod and there are no current plans for you to start it.
- You have read, understood, and signed a written consent form agreeing to take part in the trial.
Who may not be able to join:
- There are no specific exclusion criteria listed for this trial (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying."
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 857-350-4834
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The overall long-term safety of efgartigimod including the occurrence of serious infections in generalized myasthenia gravis (gMG) patients treated with efgartigimod compared to gMG patients not exposed to efgartigimod
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.